Robert Bierling
Robert Bierling publishes mostly in Organic Chemistry, Molecular Biology and Public Health, Environmental and Occupational Health, on topics such as Synthesis and biological activity, Acute Lymphoblastic Leukemia research and Mitochondrial Function and Pathology.
- World rank
- #6,543,847 of 7,710,434 ranked researchers
- Rank in Germany
- #328,726 of 364,343
- Works
- 17
- Citations
- 64
- Citations per work
- 3.8
What does Robert Bierling research?
Robert Bierling's work is mostly in Chemistry (33%), Biochemistry, Genetics and Molecular Biology (21%), Medicine (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences635.7%
- Chemistry633.3%
- Environmental Science02.4%
- Everything else426.2%
- Life Sciences421.4%
- Health Sciences316.7%
- Medicine316.7%
- 1Organic Chemistry33% of their works
- 2Molecular Biology21% of their works
- 3Public Health, Environmental and Occupational Health7% of their works
- 4Pharmacology5% of their works
- 5Oncology5% of their works
- 6Pollution2% of their works
Research topics
- Synthesis and biological activity
- Acute Lymphoblastic Leukemia research
- Mitochondrial Function and Pathology
- Biochemical and Molecular Research
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Reactions of Organic Compounds
- Synthesis of Organic Compounds
- Amino Acid Enzymes and Metabolism
Which keywords describe Robert Bierling's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Synthesis, Drug Discovery, Heterocycles, Heterocyclic Compounds, Tubulin Inhibitors and Acute Lymphoblastic Leukemia.
- Amino Acid Transporters
- Reactive Oxygen Species
- Nucleotide Metabolism
- Imidazoles
- Enzyme Regulation
- Antimicrobial
- Acute Lymphoblastic Leukemia
- Heterocyclic Compounds
- Drug Discovery
- Medicinal Chemistry
- Anticancer Agents
- Synthesis
- Heterocycles
- Tubulin Inhibitors
- Childhood Cancer
- Chromones
- Flavonoids
- Mitochondria
- Oxazolones
- Triazines
- D-Serine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Anticancer Agents62 topics
- Medicinal Chemistry62 topics
- Synthesis63 topics
- Drug Discovery42 topics
- Heterocycles42 topics
- Heterocyclic Compounds41 topic
- Tubulin Inhibitors41 topic
- Acute Lymphoblastic Leukemia31 topic
- Childhood Cancer31 topic
- Antimicrobial21 topic
- Chromones21 topic
- Enzyme Regulation21 topic
- Flavonoids21 topic
- Imidazoles21 topic
- Mitochondria21 topic
- Nucleotide Metabolism21 topic
- Oxazolones21 topic
- Reactive Oxygen Species21 topic
- Triazines21 topic
- Amino Acid Transporters11 topic
- D-Serine11 topic
Where does Robert Bierling work?
Robert Bierling's main affiliation in the publication record is Bayer (Germany), Germany.
How many publications and citations does Robert Bierling have?
OpenAlex counts 17 works and 64 citations for Robert Bierling, an h-index of 6, ranking #6,543,847 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert Bierling. Posts are plain text and can be reported.